136 related articles for article (PubMed ID: 23833124)
1. Frequent antibiotic use and second breast cancer events.
Wirtz HS; Buist DS; Gralow JR; Barlow WE; Gray S; Chubak J; Yu O; Bowles EJ; Fujii M; Boudreau DM
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1588-99. PubMed ID: 23833124
[TBL] [Abstract][Full Text] [Related]
2. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
3. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
Boudreau DM; Yu O; Chubak J; Wirtz HS; Bowles EJ; Fujii M; Buist DS
Breast Cancer Res Treat; 2014 Apr; 144(2):405-16. PubMed ID: 24557337
[TBL] [Abstract][Full Text] [Related]
4. Risk of second breast cancer events with chronic opioid use in breast cancer survivors.
Boudreau DM; Chen L; Yu O; Bowles EJA; Chubak J
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):740-753. PubMed ID: 30945381
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and outcomes following early-stage breast cancer.
Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
[TBL] [Abstract][Full Text] [Related]
6. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
[No Abstract] [Full Text] [Related]
7. Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis.
Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
Cancer Res; 2017 Nov; 77(21):6033-6041. PubMed ID: 28935814
[TBL] [Abstract][Full Text] [Related]
8. Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.
Wirtz HS; Calip GS; Buist DSM; Gralow JR; Barlow WE; Gray S; Boudreau DM
Am J Epidemiol; 2017 Apr; 185(8):661-672. PubMed ID: 28338879
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.
Kroenke CH; Chubak J; Johnson L; Castillo A; Weltzien E; Caan BJ
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582243
[TBL] [Abstract][Full Text] [Related]
10. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project.
Kwan ML; Chen WY; Flatt SW; Weltzien EK; Nechuta SJ; Poole EM; Holmes MD; Patterson RE; Shu XO; Pierce JP; Caan BJ
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):32-41. PubMed ID: 23150063
[TBL] [Abstract][Full Text] [Related]
11. Statin use and breast cancer risk in a large population-based setting.
Boudreau DM; Yu O; Miglioretti DL; Buist DS; Heckbert SR; Daling JR
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):416-21. PubMed ID: 17372235
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer recurrence in relation to antidepressant use.
Chubak J; Bowles EJ; Yu O; Buist DS; Fujii M; Boudreau DM
Cancer Causes Control; 2016 Jan; 27(1):125-36. PubMed ID: 26518198
[TBL] [Abstract][Full Text] [Related]
13. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study.
Kwan ML; Greenlee H; Lee VS; Castillo A; Gunderson EP; Habel LA; Kushi LH; Sweeney C; Tam EK; Caan BJ
Breast Cancer Res Treat; 2011 Nov; 130(1):195-205. PubMed ID: 21559824
[TBL] [Abstract][Full Text] [Related]
14. An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events.
Chubak J; Onega T; Zhu W; Buist DSM; Hubbard RA
Med Care; 2017 Dec; 55(12):e81-e87. PubMed ID: 29135770
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.
Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26631176
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic use in relation to the risk of breast cancer.
Velicer CM; Heckbert SR; Lampe JW; Potter JD; Robertson CA; Taplin SH
JAMA; 2004 Feb; 291(7):827-35. PubMed ID: 14970061
[TBL] [Abstract][Full Text] [Related]
17. Mammography use, breast cancer stage at diagnosis, and survival among older women.
McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
[TBL] [Abstract][Full Text] [Related]
18. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
19. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.
Su Y; Guo R; Xue J; Chi Y; Chi W; Wang J; Yang B; Wu J
Oncologist; 2019 Sep; 24(9):e818-e827. PubMed ID: 30842240
[TBL] [Abstract][Full Text] [Related]
20. Hazard of recurrence among women after primary breast cancer treatment--a 10-year follow-up using data from SEER-Medicare.
Cheng L; Swartz MD; Zhao H; Kapadia AS; Lai D; Rowan PJ; Buchholz TA; Giordano SH
Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):800-9. PubMed ID: 22426147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
